Continual Reassessment Method for Partial Ordering

From MaRDI portal
Revision as of 20:33, 3 February 2024 by Import240129110113 (talk | contribs) (Created automatically from import240129110113)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:2893418


DOI10.1111/j.1541-0420.2011.01560.xzbMath1274.62892WikidataQ30423577 ScholiaQ30423577MaRDI QIDQ2893418

Nolan A. Wages, John O'Quigley, Mark Conaway

Publication date: 20 June 2012

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc3141101

zbMATH Keywords

clinical trial; partial ordering; dose-finding studies; maximum tolerated dose; continual reassessment method; toxicity; drug combination; dose escalation; phase 1 trials


Mathematics Subject Classification ID

62P10: Applications of statistics to biology and medical sciences; meta analysis


Related Items

Semiparametric Dose Finding Methods for Partially Ordered Drug Combinations, Flexible use of copula‐type model for dose‐finding in drug combination clinical trials, Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information, Evaluation of phase I clinical trial designs for combinational agents along with guidance based on simulation studies, A Bayesian adaptive design in cancer phase I trials using dose combinations in the presence of a baseline covariate, A novel framework to estimate multidimensional minimum effective doses using asymmetric posterior gain and \(\epsilon\)-tapering, Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity, Adaptive clinical trial designs for phase I cancer studies



Cites Work

Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Publication:2893418&oldid=15849434"
Powered by MediaWiki